Colgate-Palmolive Company (CL) has witnessed a mixed financial performance, with its
shares down 3.25% on December 3rd, despite benefiting from what Jim Cramer of Mad Money describes as positive street sentiment. Some investors show hesitancy, demonstrated by insiders selling off approximately
US$3.5m of their holdings. Performance seems undervalued by as much as 39%, as per some analysts, and positive long-term speculation persists as Quantinno Capital Management, HighTower Advisors, and Royal London Asset Management execute large-scale share purchases. The firm's 5-year
EBITDA growth rate is reported around -0.70%, and its institutional investors saw temporary losses of 4.7% and 5.0% over separate weeks. Still,
long-term gains cannot be discounted with an impressive 59% gain for those who invested 5 years ago. The company has revised its 2024 outlook due to strong Q3 growth and reported a 21.3% YTD gain, putting it on the radar as a potentially lucrative investment. It's worth noting though that the Q3 results highlight an underperforming stock in comparison to its competitors.
Colgate-Palmolive Company CL News Analytics from Wed, 01 May 2024 07:00:00 GMT to Sat, 07 Dec 2024 20:33:00 GMT -
Rating -1
- Innovation 0
- Information 3
- Rumor -3
